Immedica Pharma AB
Arvid Cronlund is an experienced professional in drug safety, currently serving as the Head of Drug Safety at Immedica Pharma AB since September 2018. Prior roles include Head of Drug Safety and EU-QPPV at Sobi - Swedish Orphan Biovitrum AB (publ) from March 2016 to July 2018, and various positions at Swedish Orphan Biovitrum AB, including Director Drug Safety Operations and Pharmacovigilance Manager, spanning from December 2010 to March 2016. Arvid began career in drug safety at Swedish Orphan International AB as EU-QPPV and previously held the role of Head of Drug Safety at Pfizer Sweden for eight years. Arvid holds a Master of Science (MSc) in Pharmaceutical Sciences from Uppsala University, obtained between 1993 and 1998.
Immedica Pharma AB
About Immedica Pharma Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the Middle East. Welcome to the Immedica social media channels The Immedica social channels are set up to share news, updates, and company happenings with all visitors. And we want to get your input on our company information but due to the highly regulated industry we work in there are some topics that we cannot talk about online. And please note that postings by other visitors do not necessarily reflect the opinion of Immedica or confirm their accuracy. Immedica will routinely monitor comments and Immedica reserves the right to remove any posts that do not comply with our guidelines and to block anyone who violates them repeatedly. Examples of reasons for having a comment removed from a post on our social media might be: Your comment references a side effect or complaint If you would like to report an adverse event or side effects or reactions from an Immedica product it should be reported either directly to us on the Immedica Drug Safety page or to your physician. Your comment references a product or treatment As mentioned, before we work in a highly regulated industry that does not allow us to engage with the public in discussions about products – ours or other companies – or treatment options. We never provide healthcare advice; your doctor or health care provider is the person to ask. If you have a product enquiry, please email the Immedica medical department. Your comment contains abusive language We welcome your feedback, provided you share your view in a way that is respectful to our community. That it’s not inappropriate, off-topic, harassing, spamming in nature, or promoting/soliciting third-party sites, initiatives, or products Social media platforms may occasionally be unavailable, and we accept no responsibility for lack of service due to social media platform downtime.